EPPVDN consensus statement giving graded recommendations for children and young adults with a Fontan circulation and cardiovascular dysfunction, covering pulmonary vasodilators, pathway obstruction, lymphatics, heart failure and antithrombotics; many rest on expert opinion.
Guideline
Opotowsky et al. Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS